SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 1, 2026

AVLN

Avalyn Pharma Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $10.0M total
Actionable Insight ▲ Bullish

The $10M insider purchase at $18 is a strong bullish signal from both a director and a major 10% owner. Monitor for upcoming news (Phase 2/3 data, partnership, or NDA filing) as insiders rarely deploy this amount without a near-term catalyst. The stock is likely to re-rate higher if the catalyst materializes.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
AVLN ▲ +0.83% at T+60d
LONG call ✓ call won +0.83% · α vs SPY -2.74% · entry $29.07 → $29.31
Entry = T+0 close
May 1, 2026
via day close
T+1d
-5.64%
call -5.64% · α -6.44%
$27.43
settled 6mo ago
T+5d
+1.72%
call +1.72% · α -1.25%
$29.57
settled 6mo ago
T+20d
-11.52%
call -11.52% · α -17.31%
$25.72
settled 5mo ago
T+60d
+0.83%
call +0.83% · α -2.74%
$29.31
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two insiders (Director Jill Carroll and 10% owner SR ONE CAPITAL) each purchased $5M of AVLN stock on May 1, 2026, at $18/share, totaling $10M in open-market buys. This is a material insider buying cluster representing ~0.83% of the $1.2B market cap, signaling strong conviction ahead of a potential catalyst.

Key Financial Metrics

Direction
buying
Total Value
$10.0M
Insiders
2

Key Facts

  • Director Jill Carroll purchased 277,778 shares at $18.00 for $5,000,004 on May 1, 2026
  • 10% owner SR ONE CAPITAL MANAGEMENT purchased 277,778 shares at $18.00 for $5,000,004 on May 1, 2026
  • Total open-market purchases: $10,000,008, representing ~0.83% of AVLN's $1.2B market cap
  • Multiple large holders also converted derivatives (non-cash) on the same day, indicating coordinated restructuring of positions
  • CFO and CMO received equity grants on April 29-30, 2026, aligning management incentives

Financial Impact

Insider buying of $10M at $18/share, representing 0.83% of market cap

insider ownershipmarket confidence

Risk Factors

  • Insiders may be buying to support the stock ahead of a dilutive offering (note the derivative conversions)
  • No specific catalyst disclosed — buying could be pre-emptive rather than reactive to imminent positive news
  • Biotech binary risk: if the catalyst fails, the stock could decline sharply

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AVLN-1777984690183
17 reports for AVLN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AVLN — sortable, filterable
TypeNow
Sep 21, 2026
5w ago
Press Release
BULLISH ★ 5/10
$31.62 $28.32▼ −10.44%▼ −9.42%$25.83 (−18.31%)
Aug 16, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$38.25 $37.69▼ −1.46%▼ −0.27%$25.83 (−32.47%)
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$37.38 $38.97▲ +4.25%▲ +4.70%$25.83 (−30.90%)
Aug 12, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$37.38 $38.97▲ +4.25%▲ +4.70%$25.83 (−30.90%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$29.31 $30.09▲ +2.66%▲ +3.70%$25.83 (−11.87%)
Jun 17, 2026
18w ago
Press Release
NEUTRAL ★ 4/10
$29.31 $30.09▲ +2.66%▲ +3.70%$25.83 (−11.87%)
Jun 3, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$26.40 $28.53▲ +8.07%▲ +11.89%$25.83 (−2.16%)
May 5, 2026
25w ago
Press Release
NEUTRAL ★ 2/10
$27.71 $29.90▲ +7.90%▲ +6.77%$25.83 (−6.78%)
May 1, 2026
25w ago
Insider Cluster
BULLISH ★ 7/10
$29.07 $29.57▲ +1.72%▼ −1.25%$25.83 (−11.15%)
May 1, 2026
25w ago
Insider Cluster
BULLISH ★ 7/10
$29.07 $29.57▲ +1.72%▼ −1.25%$25.83 (−11.15%)
Showing 10 of 17

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026